electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled for February 11-12, 2025 in Snowbird, Utah.
CEO Dan Goldberger will be available for one-on-one meetings throughout the conference. Interested investors can arrange meetings through their BTIG representative or by contacting electroCore's investor relations team directly at investors@electrocore.com.
electroCore (Nasdaq: ECOR), un'azienda di medicina bioelettronica e benessere in fase commerciale, ha annunciato la sua partecipazione alla 12ª Conferenza Annuale BTIG su MedTech, Salute Digitale, Scienze della Vita e Strumenti Diagnostici. L'evento è programmato per 11-12 febbraio 2025 a Snowbird, Utah.
Il CEO Dan Goldberger sarà disponibile per incontri individuali durante tutta la conferenza. Gli investitori interessati possono organizzare incontri tramite il proprio rappresentante BTIG o contattando direttamente il team delle relazioni con gli investitori di electroCore all'indirizzo investors@electrocore.com.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar en fase comercial, ha anunciado su participación en la 12ª Conferencia Anual de BTIG sobre MedTech, Salud Digital, Ciencias de la Vida y Herramientas Diagnósticas. El evento está programado para 11-12 de febrero de 2025 en Snowbird, Utah.
El CEO Dan Goldberger estará disponible para reuniones individuales durante toda la conferencia. Los inversores interesados pueden organizar reuniones a través de su representante de BTIG o contactando directamente al equipo de relaciones con inversores de electroCore en investors@electrocore.com.
electroCore (Nasdaq: ECOR), 상업 단계의 생체 전자 의학 및 웰빙 회사, 가 제12회 BTIG 의료 기술, 디지털 건강, 생명 과학 및 진단 도구 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 2월 11-12일 유타주 스노우버드에서 열릴 예정입니다.
CEO Dan Goldberger는 콘퍼런스 기간 동안 1:1 미팅이 가능합니다. 관심 있는 투자자는 BTIG 대표를 통해 미팅을 조정하거나 electroCore의 투자자 관계 팀에 직접 연락하여 investors@electrocore.com으로 문의할 수 있습니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être en phase commerciale, a annoncé sa participation à la 12e Conférence Annuelle BTIG sur MedTech, Santé Numérique, Sciences de la Vie et Outils Diagnostiques. L'événement est prévu pour le 11-12 février 2025 à Snowbird, Utah.
Le PDG Dan Goldberger sera disponible pour des réunions individuelles tout au long de la conférence. Les investisseurs intéressés peuvent organiser des réunions par le biais de leur représentant BTIG ou en contactant directement l'équipe des relations avec les investisseurs d'electroCore à l'adresse investors@electrocore.com.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness in der kommerziellen Phase, hat seine Teilnahme an der 12. jährlichen BTIG-Konferenz für MedTech, digitale Gesundheit, Lebenswissenschaften und Diagnosetools angekündigt. Die Veranstaltung ist für 11.-12. Februar 2025 in Snowbird, Utah, geplant.
CEO Dan Goldberger wird während der gesamten Konferenz für eins-zu-eins-Meetings zur Verfügung stehen. Interessierte Investoren können Meetings über ihren BTIG-Vertreter vereinbaren oder direkt das Investor-Relations-Team von electroCore unter investors@electrocore.com kontaktieren.
- None.
- None.
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025 in Snowbird, Utah.
Dan Goldberger, Chief Executive Officer, will host one-on-one meetings throughout the conference. To schedule a one-on-one meeting with Mr. Goldberger, investors are encouraged out to their BTIG representative or contact the electroCore investor relations team at investors@electrocore.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) participating in the BTIG MedTech Conference 2025?
How can investors schedule meetings with electroCore (ECOR) at the BTIG Conference?
What type of meetings will electroCore (ECOR) offer at the 2025 BTIG Conference?
Where is the 2025 BTIG MedTech Conference being held for electroCore (ECOR)?
